186.1 billion yuan! Data analysis of national antibiotic market in 2015 (with top 10 sales volume of three antibiotic enterprises)

Source: Xinkangjie, April 12, 2016, since August 1, 2012, "the most severe Anti Japanese order" in history Since the formal implementation of the so-called "measures for the administration of clinical application of antimicrobial drugs", China has carried out many special renovations on the market of antibiotic prescription drugs to curb the number of antibacterial drugs used in hospitals, but the growth rate of the scale of such drugs is still at a high level According to Zhongkang CMH monitoring, in 2015, the market scale of systemic antibacterials in China reached 211.9 billion yuan, of which, the market scale of antibiotics reached 186.1 billion yuan, an increase of 8.4% year-on-year, while the growth rate of national drug market scale was only 7.6% in the same period Affected by this, a new round of "order of restraining resistance" was launched, the intensity of restriction was upgraded, and the scope of restriction was extended to village clinics 8.4% In 2015, the growth rate of antibiotics was still higher than that of the national drug market Since this year, some provinces have introduced policies and regulations to improve the rationality of using antibiotics For example, Zhejiang provincial health and Family Planning Commission issued the notice on strengthening the hierarchical management of clinical application of antimicrobial drugs, which requires the hierarchical management of clinical application of antimicrobial drugs, and at the same time, gradually stop the intravenous infusion of antimicrobial drugs to outpatients In addition to children's Hospital and pediatrics, the third level hospital took the lead in the overall stop In addition, Wenzhou health and Family Planning Commission of Zhejiang Province announced that 16 tertiary hospitals (except children's Hospital, pediatrics and emergency department) in the city will completely stop the infusion of antibiotics to outpatients, and clear the schedule The drug administration department of a city health and Family Planning Commission in Jiangsu Province informed the hospitals in the city that since April, according to the regulations of Jiangsu Province's classified management catalog of clinical application of antibiotics, the following antibiotic village clinics are not allowed to purchase: aloxicillin, amoxicillin clavulanic acid, cefotaxime, cefixime, ceftizoxime, azithromycin injection and levofloxacin injection In recent years, overuse of antibiotics and intravenous antibiotics has become a serious social problem in China, and it is endangering people's health The general population in China is becoming the "followers" and "victims" of antibiotic abuse According to the survey of the World Health Organization, about 75% of cold outpatients in China use antibiotics, and 95% of them use surgery The utilization rate of antibiotics in Chinese inpatients is as high as 80%, among which 58% use broad-spectrum antibiotics and more than two kinds of antibiotics in combination, which is far higher than the international level of 30% Since August 1, 2012, the management measures for clinical application of antibacterials, known as "the most stringent anti drug restriction order", has been officially implemented, China has carried out many special renovations on the market of antibiotic prescription drugs, to inhibit the number of antibacterials used in hospitals, but the growth rate of the scale of such drugs is still at a high level According to Zhongkang CMH monitoring, in 2015, the market scale of systemic antibacterials in China reached 211.9 billion yuan, of which, the market scale of antibiotics reached 186.1 billion yuan, an increase of 8.4% year-on-year, while the growth rate of national drug market scale was only 7.6% in the same period Affected by this, a new round of "Anti Japanese order" was launched, and the restrictions were upgraded and extended to the village clinics According to the CMH monitoring of Zhongkang, the use of antibiotics in China is mainly concentrated in grade hospitals, of which 53.3% are urban grade hospitals, 25.1% are county-level hospitals, which are in the "anti restriction" category Under the trend of upgrading and canceling outpatient infusion in large hospitals, the antibiotic market may usher in a real cold winter, and part of the demand will be transferred to basic hospitals in the future Specifically, antibiotics include 13 subcategories, among which cephalosporins, penicillins and macrolides are the main categories, with a cumulative market share of 85% in 2015 1 According to the data of cephalosporins CFDA, there are 5617 cephalosporins in China, but only 46 generic names, which shows that the market competition is very fierce From the perspective of common name, the cumulative market share of top 10 sales in 2015 is 55%, and from the perspective of enterprises, the cumulative market share of top 10 sales in 2015 is 41.6%.